SARS-CoV-2 Inactivated Vaccine (Vero Cell)     SinoVac Vaccine wholesale  Hot sale Sinopharm Vaccine

Product Description

SARS-CoV-2 Inactivated Vaccine (Vero Cell) is composed

of novel coronavirus strain after Vero cell culture,

inactivation, purification and adjuvant adsorption.

Specification: 0.5 ml/PFS, 0.5 ml per dose

Storage condition: 2-8 ℃

Manufacturer: Beijing Institute of Biological Products Co., Ltd.; Wuhan Institute of Biological Products Co., Ltd.

Product Introduction

Eligible: This product is suitable for healthy people above 18 years old.(After clinical unblinding, the age

range of inoculation could be expan

Established in 2007 in Shanghai, China, Vitaimed is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. Vitaimed product and service portfolio includes urological continence care, ostomy care, wound care, gynecological care, enteral feeding and irrigation products, and a full-service contract manufacturing business. Vitaimed products are with ISO13485, CE and FDA certificate. Vitaimed products are distributed in the United States, Germany, Greece, Italy, France, Spain, Portugal, Poland, CZ, Singapore, Thailand, Malaysia, Egypt, U.A.E., Korea, Brazil, Chile, Panama, S.Africa, Mozambique, and more than 40 other countries worldwide.

SARS-CoV-2 inactivated vaccine (Vero Cell) produced in China SinoVac has been evaluated for safety in accordance with international standards. 28 days after vaccination, the neutralizing positive rate of antibodies reached 100%.

/sars-cov-2-inactivated-vaccine-vero-cell/sars-cov-2-inactivated-vaccine-vero-cell.html